Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication May 11, 2021
- Revision received September 25, 2021
- Published online June 1, 2022.
Article Versions
- previous version (September 30, 2021 - 11:57).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2022 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.
Author Information
- 1Radiochemistry and Radiation Chemistry Key Laboratory of Fundamental Science, Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, Beijing, China;
- 2Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China; and
- 3Peking University–Tsinghua University Center for Life Sciences, Beijing, China
- For correspondence or reprints, contact Zhibo Liu (zbliu{at}pku.edu.cn).
↵*Contributed equally to this work.
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
Jump to section
Related Articles
Cited By...
- No citing articles found.